Literature DB >> 10992722

The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.

S K Yoon1, Y M Park, B H Byun, S H Bae, J M Yang, B M Ahn, Y S Lee, C D Lee, H S Sun, B S Kim.   

Abstract

BACKGROUND: Although the polyproteins of hepatitis C virus(HCV) are processed and formed in nearly equimolar amounts, individual functional proteins have a discrepancy in their time of appearance following HCV infection and eliciting immune response. This study was conducted to compare the reactivity toward regional specific HCV protein in relation to virological characteristics, including HCV genotype and HCV replication.
METHODS: Sera from forty-five patients with chronic HCV infection were analyzed through the experiments of the recombinant immunoblot assay(RIBA-2), HCV genotyping and HCV RNA quantitation.
RESULTS: The frequencies of seropositivity to C22-3, C33C, C100-3 and 5-1-1 proteins were 91.1%, 91.1%, 64.4% and 53.3%, respectively, of all the patients, and thus the antibodies to C22-3 and C33C proteins were found more frequently (p < 0.05). The antibody responses between core or NS3 proteins and NS4 proteins showed more discrepancy in the HCC group than that in the CH group, implying a possibility of oncogenic potential of core or NS3 gene in hepatocarcinogenesis. The detection rate of antibodies to C22-3 and C33C, in accordance with serum HCV RNA levels, was significantly higher in highly viremic patients than that in low viremic patients (p < 0.05). Antibodies to C22-3, C33C, C100-3 and 5-1-1 were also found more frequently in patients with HCV genotype 1b, compared to those with HCV genotype 2a (p < 0.05).
CONCLUSION: These results suggest that antibody detection of HCV may depend on the virological characteristics of HCV, the levels of HCV replication and HCV genotype and, therefore, HCV RNA detection using RT-PCR technique is essential for confirmatory diagnosis for HCV infection. Furthermore, the HCV core or NS3 Protein may play important role in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992722      PMCID: PMC4531759          DOI: 10.3904/kjim.2000.15.2.109

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  37 in total

1.  Seroepidemiological study on hepatitis delta virus infection in the Irabu Islands, Okinawa, Japan.

Authors:  H Sakugawa; H Nakasone; H Shokita; Y Kawakami; N Nakachi; H Adaniya; T Mizushima; T Nakayoshi; F Kinjo; A Saito; M Taira; H Takaesu; N Onga
Journal:  J Gastroenterol Hepatol       Date:  1997-04       Impact factor: 4.029

2.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

4.  Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

Authors:  D Qu; J S Li; L Vitvitski; S Mechai; F Berby; S P Tong; F Bailly; Q S Wang; J L Martin; C Trépo
Journal:  J Hepatol       Date:  1994-07       Impact factor: 25.083

5.  Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction.

Authors:  S Kaneko; S Murakami; M Unoura; K Kobayashi
Journal:  J Med Virol       Date:  1992-08       Impact factor: 2.327

6.  Persistent hepatitis C virus infection after liver transplantation: clinical and virological features.

Authors:  D R Gretch; C E Bacchi; L Corey; C dela Rosa; R R Lesniewski; K Kowdley; A Gown; I Frank; J D Perkins; R L Carithers
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

7.  The relationship of histology to genotype in chronic HCV infection.

Authors:  J C Booth; G R Foster; T Levine; H C Thomas; R D Goldin
Journal:  Liver       Date:  1997-06

8.  Clinical backgrounds of the patients having different types of hepatitis C virus genomes.

Authors:  N Takada; S Takase; N Enomoto; A Takada; T Date
Journal:  J Hepatol       Date:  1992-01       Impact factor: 25.083

9.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.

Authors:  D Sakamuro; T Furukawa; T Takegami
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  Predictive factors for beneficial response to interferon-alfa therapy in chronic hepatitis C.

Authors:  S K Yoon; S S Kim; Y M Park; K S Shim; C D Lee; H S Sun; D H Park; B S Kim; W S Ryu; J M Cho
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884

View more
  1 in total

1.  Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections.

Authors:  Kelly E Coller; Michael G Berg; Matthew Frankel; Kenn Forberg; Rita Surani; Charles Y Chiu; John Hackett; George J Dawson
Journal:  J Clin Microbiol       Date:  2016-05-25       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.